An Investigational Drug Study to Assess Weight Loss in Patients With Type 2 Diabetes Mellitus (0364-011)(TERMINATED)

NCT00430742 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

600

Enrollment

INDUSTRY

Sponsor class

Stopped The overall profile does not support development for obesity

Conditions

Obesity Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus

Interventions

DRUG: Taranabant
DRUG: Comparator: Placebo

Sponsor

Merck Sharp & Dohme LLC